|
|
ÂÒ | 9 | ![](/images/barhorange.gif) | 2.70 |
ÂÒʵÃÕ¹ÔÊÔ§àËËÁÍÁÕ | 9 | ![](/images/barhorange.gif) | 2.70 |
ËéͧÊÁØ´ã¹»ÃÐà·Èä·Â | 6 | ![](/images/barhorange.gif) | 1.80 |
¡ÒâÖé¹·ÐàºÕ¹à¤Ã×èͧÊíÒÍÒ§ | 5 | ![](/images/barhorange.gif) | 1.50 |
ËéͧÊÁØ´ÍÂ. | 4 | ![](/images/barhorange.gif) | 1.20 |
ÂÒá¡éä¢éËÇÑ´ | 4 | ![](/images/barhorange.gif) | 1.20 |
«Ù¤ÃÒâÅÊ ÍѹµÃÒ | 4 | ![](/images/barhorange.gif) | 1.20 |
ÃÐàºÕº¢Í Í | 4 | ![](/images/barhorange.gif) | 1.20 |
ª¹Ô´¢Í§ÂÒªÒ | 4 | ![](/images/barhorange.gif) | 1.20 |
˹ѧÊ×ÍãËÁè | 3 | ![](/images/barhorange.gif) | 0.90 |
»ÃСÒÈ¡ÃзÃǧÊÒ¸ÒóÊØ¢ ©ºÑº·Õè 184/2546 | 3 | ![](/images/barhorange.gif) | 0.90 |
¢Í͹ØÒµÊè§ÍÍ¡ÍÒËÒà | 3 | ![](/images/barhorange.gif) | 0.90 |
ͧ¤ì¡ÒÃÍÒËÒÃáÅÐÂÒ | 3 | ![](/images/barhorange.gif) | 0.90 |
¤ÙèÁ×Í¡ÒÃâ¦É³Ò¢ÒÂÂÒ »Õ 2551 | 3 | ![](/images/barhorange.gif) | 0.90 |
¹íÒà¢éÒÍÒËÒà | 3 | ![](/images/barhorange.gif) | 0.90 |
¾ÃÐÃÒªºÑѵÔà¤Ã×èͧÊÓÍÒ§ (©ºÑº·Õè 2) ¾.È. 2518 | 3 | ![](/images/barhorange.gif) | 0.90 |
¡ÒâÖé¹·ÐàºÕ¹ Í | 3 | ![](/images/barhorange.gif) | 0.90 |
¤ÙèÁ×Í¡ÒâÍ͹ØÒµâ¦É³ÒÍÒËÒà | 3 | ![](/images/barhorange.gif) | 0.90 |
»ÃСÒÈ¡ÃзÃǧÊÒ¸ÒóÊØ¢ ©ºÑº·Õè 104 Çѵ¶ØÍÍ¡ ºÑªÕ | 3 | ![](/images/barhorange.gif) | 0.90 |
á¼¹¡ÒÃÊ͹ ÍÂ.¹éÍ | 3 | ![](/images/barhorange.gif) | 0.90 |
âËÂè§ àËÔ § ÊÃþ¤Ø³ | 3 | ![](/images/barhorange.gif) | 0.90 |
ÂҪش ¤×Í | 2 | ![](/images/barhorange.gif) | 0.60 |
¡®ËÁÒ àÃ×èͧ ¡ÒÃáÊ´§©ÅÒ¡ ¢Í§ ÇØé¹ÊÓàÃç¨ÃÙ» ¢¹ÁàÂÅÅÕè 87 | 2 | ![](/images/barhorange.gif) | 0.60 |
¨Ø´á¢ç§¢Í§¡ÒúԹä·Â | 2 | ![](/images/barhorange.gif) | 0.60 |
¡ÒùÓà¢éÒÂÒ¡ÒùÓà¢éÒÊè§ÍÍ¡ | 2 | ![](/images/barhorange.gif) | 0.60 |
¾ÃÐÃÒªºÑѵÔà¤Ã×èͧÊÓÍÒ§2517 | 2 | ![](/images/barhorange.gif) | 0.60 |
ÂÒʵÕÅ ¹ÔÊÔ§àË | 2 | ![](/images/barhorange.gif) | 0.60 |
á¡é ʶҹ·Õè¼ÅÔµäÁè¼èҹࡳ±ì gmp | 2 | ![](/images/barhorange.gif) | 0.60 |
cosmetic hot issue | 2 | ![](/images/barhorange.gif) | 0.60 |
ºÃÔ¡ÒÃËéͧÁËÒÇÔ·ÂÒÅѵèÒ§æ | 2 | ![](/images/barhorange.gif) | 0.60 |
¡ÒùíÒà¢éÒà¤Ã×èͧÁ×Íá¾·Âì | 2 | ![](/images/barhorange.gif) | 0.60 |
ÇÒÃì¿ÒÃÔ¹ | 2 | ![](/images/barhorange.gif) | 0.60 |
¤³Ð¡ÃÃÁ¡Òà ¾ÃÐÃÒªºÑѵÔà¤Ã×èͧÊÓÍÒ§ | 2 | ![](/images/barhorange.gif) | 0.60 |
àÍÍÃÕè¡ÃзÃǧÊÒ¸ÒóÊØ¢»Õ2555 | 2 | ![](/images/barhorange.gif) | 0.60 |
ãºÍ¹ØÒµÔÁÕäÇé㹤Ãͺ¤Ãͧ«Öè§Çѵ¶ØÍѹµÃÒ english version | 2 | ![](/images/barhorange.gif) | 0.60 |
hot issue ¾ÔÉÇÔ·ÂÒ | 2 | ![](/images/barhorange.gif) | 0.60 |
ÊÃþ¤Ø³¾ÒÃÒ૵ÒÁÍÅ | 2 | ![](/images/barhorange.gif) | 0.60 |
µÐ¡ÑèÇ ä¢èàÂÕèÂÇÁéÒ ÇԨѠ| 2 | ![](/images/barhorange.gif) | 0.60 |
ÂÒ | 2 | ![](/images/barhorange.gif) | 0.60 |
“ÍÕ ¤ÍÁâ¾ÊÔÁ†| 2 | ![](/images/barhorange.gif) | 0.60 |
ËÅѡࡳ±ì fda quality awards | 2 | ![](/images/barhorange.gif) | 0.60 |
¾ÒÃÒ૵ÒÁÍÅ ÊÃþ¤Ø³ | 2 | ![](/images/barhorange.gif) | 0.60 |
lecithin ¤×Í | 2 | ![](/images/barhorange.gif) | 0.60 |
certificate of free sale Ẻ¿ÍÃìÁ¡ÒâÍ͹ØÒµ ˹ѧÊ×ÍÃѺÃͧ¡ÒâÒ | 2 | ![](/images/barhorange.gif) | 0.60 |
à´ç§¡Õè | 2 | ![](/images/barhorange.gif) | 0.60 |
»ÃÐàÀ·¢Í§ÂÒªÒ | 2 | ![](/images/barhorange.gif) | 0.60 |
swot¡ÒúԹä·Â | 2 | ![](/images/barhorange.gif) | 0.60 |
»ÃСÒÈ¡ÃзÃǧÊÒ¸ÒóÊØ¢ (©ºÑº·Õè 281) ¾.È.2547 | 2 | ![](/images/barhorange.gif) | 0.60 |
ÃÒª×èÍâç§Ò¹ÅÙ¡ªÔé¹»ÅÒ | 2 | ![](/images/barhorange.gif) | 0.60 |
«Ù¤ÃÒâÅÊ | 2 | ![](/images/barhorange.gif) | 0.60 |
ÇԨѡÒÃÊÅÒµÑǢͧÂÒ¦èÒáÁŧ | 2 | ![](/images/barhorange.gif) | 0.60 |
¾ÅÙ¤ÒÇ ¼Å¡ÃзºµèÍÊØ¢ÀÒ¾ | 1 | ![](/images/barhorange.gif) | 0.30 |
ͧ¤ì¡ÒÃÁÕÂÒclopidogrel | 1 | ![](/images/barhorange.gif) | 0.30 |
fda thai pseudoephedrene | 1 | ![](/images/barhorange.gif) | 0.30 |
àËç´ËÙ˹٢ÒÇ.¹Óà¢éÒ | 1 | ![](/images/barhorange.gif) | 0.30 |
¢ÒÂÂÒÊÒÁÑ»ÃШíÒºéÒ¹ µéͧ¢Í͹ØÒµËÃ×ÍäÁè | 1 | ![](/images/barhorange.gif) | 0.30 |
ÂÒ ÊµÃÕ ¹Ô ÊÔ§ àË | 1 | ![](/images/barhorange.gif) | 0.30 |
ÊÒÃÃÐàË ¡®¡ÃзÃǧ ©ºÑº·Õè 2 | 1 | ![](/images/barhorange.gif) | 0.30 |
¾ÃÐÃÒªºÑѵÔÂÒàʾµÔ´ãËéâ·É ¾Ø·¸ÈÑ¡ÃÒª 2542 | 1 | ![](/images/barhorange.gif) | 0.30 |
"áËÅè§ÊÒÃʹà·È·Ò§ÊØ¢ÀÒ¾" | 1 | ![](/images/barhorange.gif) | 0.30 |
ÂÒºÃÃà·ÒÍÒ¡ÒÃËÇÑ´ | 1 | ![](/images/barhorange.gif) | 0.30 |
á¾é ppd | 1 | ![](/images/barhorange.gif) | 0.30 |
atypical fracture reported case | 1 | ![](/images/barhorange.gif) | 0.30 |
»ÃСÒÈ¡ÃзÃǧÊÒ¸ÒóÊØ¢ ©ºÑº·Õè 84 ¾.È.2527 | 1 | ![](/images/barhorange.gif) | 0.30 |
¡ÅÂØ·¸ì¢Í§¡ÒúԹä·Â | 1 | ![](/images/barhorange.gif) | 0.30 |
ÊÒ¸ÒóÊØ¢¡ÒÃÇÔ¨ÑÂÊÒúÍáá«ì | 1 | ![](/images/barhorange.gif) | 0.30 |
ÅѡɳТͧ ¡ÃÐà·ÕÂÁ | 1 | ![](/images/barhorange.gif) | 0.30 |
àÅ¢·ÐàºÕ¹ÂÒ g244/43 | 1 | ![](/images/barhorange.gif) | 0.30 |
http://www.fda.moph.go.th/ | 1 | ![](/images/barhorange.gif) | 0.30 |
¤ÃÕÁÁÔÊà´Âì | 1 | ![](/images/barhorange.gif) | 0.30 |
à¾ÔèÁ ÊÁÃöÀÒ¾ ·Ò§ à¾È | 1 | ![](/images/barhorange.gif) | 0.30 |
¾ÒÃÒ૵ÒÁÍŪ¹Ô´àÁç´ ÊÃþ¤Ø³ | 1 | ![](/images/barhorange.gif) | 0.30 |
»ÃÐàÁÔ¹ãªéÂÒ ceftazidime | 1 | ![](/images/barhorange.gif) | 0.30 |
ºÃÔÉÑ· à¨ÃÔâÍʶ ¨íÒ¡Ñ´ | 1 | ![](/images/barhorange.gif) | 0.30 |
hot issue ¾ÔÉÇԷ¹ÔàÇȹì | 1 | ![](/images/barhorange.gif) | 0.30 |
ÇÔà¤ÃÒÐËì ¡ÒúԹä·Â | 1 | ![](/images/barhorange.gif) | 0.30 |
»ÃСÒÈ¡ÃзÃǧÊÒ¸ÒóÊØ¢ ©ºÑº·Õè 106 | 1 | ![](/images/barhorange.gif) | 0.30 |
"ª¹Ô´Ò »âªµÔ¡ÒÃ" | 1 | ![](/images/barhorange.gif) | 0.30 |
¼ÅäÁé´Í§µÅÒ´ÁËÒ¹Ò¤ | 1 | ![](/images/barhorange.gif) | 0.30 |
glutathione ÊÙµÃâ¤Ã§ÊÃéÒ§ | 1 | ![](/images/barhorange.gif) | 0.30 |
¤ÃÕÁ cta ¡ÅèͧÊÕ¢ÒǤҴÊéÁ ÁÕÃÙ»âÊÁÁÕµé¹ãºáÅд͡ ©ÅÒ¡ÀÒÉÒ¨Õ¹ | 1 | ![](/images/barhorange.gif) | 0.30 |
¤ÇÒÁᵡµèÒ§ÃÐËÇèÒ§ÂÒªÒ¡ÅØèÁ ester áÅÐ ¡ÅØèÁ amide ã¹´éÒ¹àÀÊѪ¨Å¹ÈÒʵÃìáÅоÔÉÇÔ·ÂÒ | 1 | ![](/images/barhorange.gif) | 0.30 |
¢éÍÁÙÅà¡ÕèÂǡѺ¼ÅÔµÀѳ±ìÊØ¢ÀÒ¾ | 1 | ![](/images/barhorange.gif) | 0.30 |
ÅÙ¡àËÁç¹ ÁÕâ·ÉÍÂèÒ§äà | 1 | ![](/images/barhorange.gif) | 0.30 |
»ÃСÒÈ¡ÃзÃǧÊÒ¸ÒóÊØ¢ ©ºÑº·Õè 295 | 1 | ![](/images/barhorange.gif) | 0.30 |
»ÃÐ⪹ìacesulfame k | 1 | ![](/images/barhorange.gif) | 0.30 |
¡Ãкǹ¡ÒüÅÔµ¡Ø¹àªÕ§ | 1 | ![](/images/barhorange.gif) | 0.30 |
thai fda | 1 | ![](/images/barhorange.gif) | 0.30 |
éhow much screen time is too for children | 1 | ![](/images/barhorange.gif) | 0.30 |
äǹì»ÅÍÁ | 1 | ![](/images/barhorange.gif) | 0.30 |
¡Ò÷ÓÃÐàºÔ´¡Ãлͧ | 1 | ![](/images/barhorange.gif) | 0.30 |
¼ÅÔµÀѳ±ì¨Ò¡ á»Ð¡ëÇ | 1 | ![](/images/barhorange.gif) | 0.30 |
ÂÒʵÃÕÊÔ§àË ËÁÍÁÕ | 1 | ![](/images/barhorange.gif) | 0.30 |
¢Ñ鹵͹¡ÒùÓà¢éÒ Í.Â. | 1 | ![](/images/barhorange.gif) | 0.30 |
¡®ËÁÒÂÂÒã¹ÊѵÇì | 1 | ![](/images/barhorange.gif) | 0.30 |
¡ÒúԹä·Â swot | 1 | ![](/images/barhorange.gif) | 0.30 |
¡®ËÁÒ ÍÂ. | 1 | ![](/images/barhorange.gif) | 0.30 |
âËÂè§àËÔ§ ä´éÃѺãºÍ¹ØÒµÔ¨Ò¡¤³Ð¡ÃÃÁ¡ÒÃÍÒËÒÃáÅÐÂÒËÃ×ÍÂѧ | 1 | ![](/images/barhorange.gif) | 0.30 |
ࡳ±ì¡ÒûÃÐàÁÔ¹ÂÒ ceftazidime | 1 | ![](/images/barhorange.gif) | 0.30 |
§Ò¹ÇԨѠ¿Í¡¢ÒÇã¹ÍÒËÒà | 1 | ![](/images/barhorange.gif) | 0.30 |